Difference between revisions of "Elsevier BV"
m (David moved page Elsevier to Elsevier BV) |
|||
| Line 9: | Line 9: | ||
==See also== | ==See also== | ||
| − | + | ||
| + | ===Subsidiaries=== | ||
| + | [[Excerpta Medica]] | ||
| + | |||
| + | ===Journals=== | ||
| + | [[Australasian Journal of Bone & Joint Medicine]] | ||
==Notes== | ==Notes== | ||
<references/> | <references/> | ||
[[Category:Publishers]] | [[Category:Publishers]] | ||
Revision as of 10:15, 5 September 2013
Elsevier B.V. is a publishing company which publishes medical and scientific literature. It is a part of the Reed Elsevier group. Based in Amsterdam, the company has operations in the United Kingdom, USA, Brazil and elsewhere.
Leading journals include The Lancet and Cell, books such as Gray's Anatomy, the ScienceDirect collection of electronic journals, the Trends and Current Opinion series of journals, and the online citation database Scopus. Its free researcher collaboration tool, 2collab, launched in 2007, was discontinued in 2011.
Elsevier partners 'with a global community of 7,000 journal editors, 70,000 editorial board members, 300,000 reviewers and 600,000 authors.[1]
In 2010, Elsevier reported a profit margin of 36% on revenues of US$3.2 billion.[2] Elsevier accounts for 28% of the revenues of the Reed Elsevier group (₤1.5b of 5.4 billions in 2006). In operating profits, it represents a bigger fraction of 44% (₤395 of 880 millions).[3] Adjusted operating profits rose by 10% from 2005 to 2006.[4] Elsevier's high profit margins, copyright practices and publishing ethics have subjected it to much criticism.
Contents
See also
Subsidiaries
Journals
Australasian Journal of Bone & Joint Medicine
Notes
- ↑ Elsevier 'Elsevier at a glance', accessed 5 September 2013
- ↑ Thomas Lin Mathematicians Organize Boycott of a Publisher The New York Times 13 February 2012
- ↑ Reed Elsevier | Annual Report and Financial Statements 2006
- ↑ Reed Elsevier | Annual Report and Financial Statements 2006
